1. Home
  2. AVTR vs MDGL Comparison

AVTR vs MDGL Comparison

Compare AVTR & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTR
  • MDGL
  • Stock Information
  • Founded
  • AVTR 1904
  • MDGL 2011
  • Country
  • AVTR United States
  • MDGL United States
  • Employees
  • AVTR N/A
  • MDGL N/A
  • Industry
  • AVTR Biotechnology: Laboratory Analytical Instruments
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVTR Industrials
  • MDGL Health Care
  • Exchange
  • AVTR Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • AVTR 8.5B
  • MDGL 9.6B
  • IPO Year
  • AVTR 2019
  • MDGL N/A
  • Fundamental
  • Price
  • AVTR $11.47
  • MDGL $486.05
  • Analyst Decision
  • AVTR Buy
  • MDGL Strong Buy
  • Analyst Count
  • AVTR 13
  • MDGL 13
  • Target Price
  • AVTR $15.31
  • MDGL $518.25
  • AVG Volume (30 Days)
  • AVTR 13.7M
  • MDGL 384.9K
  • Earning Date
  • AVTR 10-29-2025
  • MDGL 11-04-2025
  • Dividend Yield
  • AVTR N/A
  • MDGL N/A
  • EPS Growth
  • AVTR N/A
  • MDGL N/A
  • EPS
  • AVTR N/A
  • MDGL N/A
  • Revenue
  • AVTR $6,575,200,000.00
  • MDGL $740,640,000.00
  • Revenue This Year
  • AVTR N/A
  • MDGL $395.75
  • Revenue Next Year
  • AVTR $0.43
  • MDGL $65.73
  • P/E Ratio
  • AVTR N/A
  • MDGL N/A
  • Revenue Growth
  • AVTR N/A
  • MDGL 864.21
  • 52 Week Low
  • AVTR $10.83
  • MDGL $265.00
  • 52 Week High
  • AVTR $23.32
  • MDGL $496.98
  • Technical
  • Relative Strength Index (RSI)
  • AVTR 35.54
  • MDGL 69.34
  • Support Level
  • AVTR $11.07
  • MDGL $399.00
  • Resistance Level
  • AVTR $11.82
  • MDGL $496.98
  • Average True Range (ATR)
  • AVTR 0.63
  • MDGL 23.46
  • MACD
  • AVTR -0.36
  • MDGL 6.23
  • Stochastic Oscillator
  • AVTR 12.14
  • MDGL 91.02

About AVTR Avantor Inc.

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: